JORDAN KIRCHGESSNER: Open Payments
NPI 1942679063 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$346 in 18 payments from 11 companies in 2025. Trend: 2023 $341 · 2024 $635 · 2025 $346
Food & beverage: $346
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $59 |
| Neurocrine BioSciences, Inc. | 3 | $56 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $52 |
| Lundbeck LLC | 2 | $44 |
| Novo Nordisk Inc | 1 | $22 |
| Exact Sciences Corporation | 1 | $21 |
| Alkermes, Inc. | 1 | $19 |
| AstraZeneca Pharmaceuticals LP | 1 | $19 |
| Janssen Pharmaceuticals, Inc | 1 | $18 |
| Teva Pharmaceuticals USA, Inc. | 1 | $18 |
Products named: INGREZZA, CAPLYTA, ABILIFY ASIMTUFII, MAVYRET, Rybelsus, Cologuard Collection Kit, ARISTADA, AIRSUPRA.
Industry payments across KY — which companies pay providers there.
